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noncaseating granulomatous inflammation involving virtu-
ally every organ of the body and resulting in tissue
destruction and impairment of organ function. More than
90% of patients have clinical presentations of asymptomatic
hilar lymphadenopathy or pulmonary, cutaneous, or ocular
involvement. Autopsy studies reported myocardial
involvement in approximately 13e20% of the patients. The
incidence of fatal cases was estimated at 25 per 100,000
but may be much higher in the Japanese population.1 Iso-
lated sarcoid heart disease without other systemic
sarcoidosis precludes physicians from recognizing this
subset of the population. The inflammation could be
insidious, cause severe functional impairment of the heart
or lethal arrhythmia, and even sudden death if the
conduction system is affected. We present our experience
with sarcoid heart disease mimicking idiopathic dilated
cardiomyopathy in heart transplantation.
Three patients (one female, two males) age 29-47 years
suffered from progressive dyspnea and leg edema with
exercise intolerance. One patient had complete* Corresponding author. Department of Pathology, National
Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei
10051, Taiwan.
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on electrocardiogram. Echocardiogram showed four-
chamber dilatation and global hypokinesia with regional
wall abnormalities. Computed tomography of the chest in
one patient confirmed no evidence of bilateral hilar
lymphadenopathy. Idiopathic dilated cardiomyopathy was
diagnosed in all three patients; they underwent orthotopic
heart transplantation. The explanted hearts consisted of
generally dilated ventricles with patent coronary arteries
(Fig. 1A). Extensive fibrosis of the left ventricle and the
interventricular septum was seen in all patients. Micro-
scopically, pancardiac involvement by noncaseating gran-
ulomatous inflammation (Fig. 1B) was predominant in the
left ventricle and interventricular septum. Sections showed
scattered multinuclear giant cells with occasional eosino-
phils, mimicking the clinical picture of giant cell myocar-
ditis (Fig. 1C). Cytoplasmic asteroid bodies can be
discernible in giant cells (Fig. 1C, inset), which also
encased large vessels and induced vasculitis (Fig. 1D).
Immunohistochemically, the giant cells stained for CD68
antibody but were negative for smooth-muscle actin. The
posttransplant course was all uneventful.
Cardiac sarcoidosis is often overlooked clinically,
particularly if the effect on the heart is predominant or
isolated. In 1977, Roberts et al2 described that most
patients in their necropsy study who died from cardiac
sarcoidosis lacked clinical features of extracardiac& Formosan Medical Association. All rights reserved.
Figure 1 (A) Gross specimen of right ventricle from case 3. There was extensive fibrosis of the interventricular septum (arrows),
with the asterisk indicating relative sparing of the right ventricle. (B) The arrowheads point to noncaseating granulomatous
inflammation with destruction of myocardium (hematoxylin and eosin stain, 100). (C) High-power magnification shows scattered
multinuclear giant cells between necrotic myofibers resembling the clinical picture of giant cell myocarditis, which may be mis-
identified with endocardial biopsy (hematoxylin and eosin stain, 200). Many cytoplasmic asteroid bodies are found in all three
cases (inset, hematoxylin and eosin stain, 400). (D) Vasculitis induced by multinucleated giant cells with destruction of vascular
wall (hematoxylin and eosin stain, 100).
500 J.-H. Tsai et al.disease. Because of left side predominance, cardiac
sarcoidosis is often difficult to diagnose with right
ventricle endomyocardial biopsy. Therefore, the guide-
lines published by the Japanese Society of Sarcoidosis and
Other Granulomatous Disorders in 2006 suggest clinical
cardiac involvement by sarcoidosis can be otherwise
established by demonstration of clinical signs and symp-
toms and/or abnormalities seen on electrocardiogram,
echocardiogram, and other imaging studies associated
with extracardiac sarcoidosis evidence.3
Cardiac sarcoidosis is a potentially controllable disease
with steroid and antiarrhythmic devices that deserves
wider recognition for its occurrence. With early diagnosis,
deterioration of cardiac sarcoidosis might be prevented by
corticosteroid therapy.4,5 Heart transplantation offers
a rescue therapy for severe heart failure or refractory
arrhythmia, and the prognosis of transplantation in
cardiac sarcoidosis seems to be favorable in 1-year
survival but has not been completely verified. Recurrence
of granulomas in the allografts was reported, and theseare treated with long-term steroid and immunosuppres-
sant therapy.
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